Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2010
05/27/2010US20100130587 METHODS OF TREATING CANCER USING siRNA MOLECULES DIRECTED AGAINST CD24
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130579 Cancer therapy
05/27/2010US20100130576 Pharmaceutical composition
05/27/2010US20100130564 Small molecule inhibitors of bcl6
05/27/2010US20100130549 Psychotropic compounds, compositions and methods of use
05/27/2010US20100130544 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related methods and compositions
05/27/2010US20100130532 Reduction of imiquimod impurities in pharmaceutical creams
05/27/2010US20100130530 Reduction of imiquimod impurities using refined oleic acid
05/27/2010US20100130525 Aqueous solution preparation containing camptothecin compounds
05/27/2010US20100130523 Mono-hydrochloric salts of an inhibitor of histone deacetylase
05/27/2010US20100130520 Combination therapy
05/27/2010US20100130519 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii
05/27/2010US20100130518 Mapk/erk kinase inhibitors
05/27/2010US20100130506 Organic Compounds
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130503 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130497 Therapeutic Compounds
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130493 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer
05/27/2010US20100130492 Morpholinopurine derivatives
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130488 Pyrazolo-Pyrimidines as Casein Kinase II (CK2) Modulators
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130473 Compounds
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130466 Triazolyl aminopyrimidine compounds
05/27/2010US20100130464 Pharmaceutical compounds
05/27/2010US20100130463 6-substituted estradiol derivatives and methods of use
05/27/2010US20100130449 Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130432 Non-Natural Amino Acids and Neurotensin Analogues Thereof
05/27/2010US20100130421 Biomodulators for treatment or prevention of disease
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130418 P2X7 Inhibition Of Epithelial Cancers And Papillomas
05/27/2010US20100130409 Cyclic peptide cxcr4 antagonists
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129478 Plant Extracts and Methods and Uses Therefore
05/27/2010US20100129470 Method of treating brain cancer
05/27/2010US20100129410 Methods and Immunogenic Cell Preparations for Treating Antigen-Associated Diseases
05/27/2010US20100129407 Tuberculosis Vaccine
05/27/2010US20100129390 Dkk1 as a universal tumor vaccine for immunotherapy of cancers
05/27/2010US20100129384 Taci-immunoglobulin fusion proteins
05/27/2010US20100129382 Combination therapy for the treatment of tumors
05/27/2010US20100129379 Stabilized antibody formulations and uses thereof
05/27/2010US20100129373 Vegf-specific human antibody
05/27/2010US20100129370 Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
05/27/2010US20100129369 c-Met Antibodies
05/27/2010US20100129363 Methods and compositions using pde4 inhibitors for the treatment and management of cancers
05/27/2010US20100129356 Compositions and methods for modulating vascular development
05/27/2010US20100129350 Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives
05/27/2010US20100129325 Seneca valley virus based compositions and methods for treating disease
05/27/2010US20100129320 Quinoline derivatives for modulating dna methylation
05/27/2010US20100129315 Anti-MN Antibodies and Methods of Using Same
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/27/2010US20100129313 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
05/27/2010CA2781591A1 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010CA2744407A1 New formulations with anti-neoplastic activity
05/27/2010CA2744351A1 New compounds
05/27/2010CA2744158A1 Anti-angiogenesis therapy for the treatment of breast cancer
05/27/2010CA2744154A1 Pyrazolopyridine pi3k inhibitor compounds and methods of use
05/27/2010CA2744134A1 New therapy and medicament using integrin ligands for treating cancer
05/27/2010CA2744031A1 Anticancer combination comprising docetaxel and an antisense oligonucleotide
05/27/2010CA2744030A1 Combination therapy for the treatment of cancer
05/27/2010CA2742946A1 Antioxidant
05/27/2010CA2742790A1 Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound
05/27/2010CA2741839A1 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
05/27/2010CA2740589A1 Compounds that expand hematopoietic stem cells
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189471A1 Foxm1 peptide and medicinal agent comprising the same
05/26/2010EP2189470A1 Tumor antigens
05/26/2010EP2189461A1 Crystalline irinotecan hydrochloride and methods for the preparation thereof
05/26/2010EP2189459A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010EP2189443A1 Tricyclic amide compound
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2189161A1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
05/26/2010EP2189158A1 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer
05/26/2010EP2188396A2 Gene silencing of the brother of the regulator of imprinted sites (boris)
05/26/2010EP2188313A1 Human c-fms antigen binding proteins
05/26/2010EP2188312A2 Novel antibodies inhibiting c-met dimerization, and uses thereof
05/26/2010EP2188310A1 Humanized anti-fgf19 antagonists and methods using same
05/26/2010EP2188301A2 Novel steroidal esters of 17-oximino-5-androsten-3 beta-ol
05/26/2010EP2188297A1 Pyrrolo ý2,1-c¨ý1, 4¨benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent
05/26/2010EP2188296A1 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods
05/26/2010EP2188292A1 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d]pyrimidin-4-yl) amino]benzamide derivatives as igf-1r inhibitors for the treatment of cancer
05/26/2010EP2188291A2 Fused bicyclic pyrimidines
05/26/2010EP2188290A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents
05/26/2010EP2188289A2 (7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation
05/26/2010EP2188283A1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
05/26/2010EP2188278A1 Phthalazinone derivatives
05/26/2010EP2188276A1 Substituted hydantoins
05/26/2010EP2188271A2 Heterocyclic compounds and uses as anticancer agents
05/26/2010EP2188267A2 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP2188260A1 Therapeutic quinoline and naphthalene derivatives
05/26/2010EP2188259A1 Method of making and administering quinoline derivatives as anti-cancer agents
05/26/2010EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
1 ... 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 ... 2211